HEXO Corp. a leading producer of high-quality cannabis products, today announced that it has repaid the total outstanding principal amount of the Company’s 8% unsecured convertible debentures issued December 5, 2019, which matured on December 5, 2022 in the amount of C$40.14 million together with all accrued and unpaid interest.
HEXO Corp, today announced the execution of a long-term supply agreement with Entourage Health Corp., a Canadian producer and distributor of award-winning cannabis products.
Under the Supply Agreement, HEXO will provide Entourage with bulk dried cannabis and soft gel capsules, to be marketed to patients and consumers under Entourage’s family of brands.
HEXO Corp. today announced a correction to its press release issued on October 31, 2022, announcing the Company’s financial results for the fiscal year ended July 31, 2022.
150000 KG
–
ANNUAL PRODUCTION CAPACITY
1200 +
–
EMPLOYEES
400+
–
POINTS OF QUALITY CONTROL
Want to keep in touch? We’ll send you our latest updates. You can unsubscribe at any time.